Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional state
- 31 July 2000
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 68 (2), 291-298
- https://doi.org/10.1016/s0168-3659(00)00272-8
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Polymers Applied in Solid Dispersion TechnologyClinical Research and Regulatory Affairs, 1998
- Physicochemical and Physiological Mechanisms for the Effects of Food on Drug Absorption: The Role of Lipids and pHJournal of Pharmaceutical Sciences, 1997
- Influence of stabilizing agents and preparative variables on the formation of poly(d,l-lactic acid) nanoparticles by an emulsification-diffusion techniqueInternational Journal of Pharmaceutics, 1996
- pH-Sensitive Nanoparticles: An Effective Means to Improve the Oral Delivery of HIV-1 Protease Inhibitors in DogsPharmaceutical Research, 1996
- Pharmacokinetics of a Novel HIV-1 Protease Inhibitor Incorporated into Biodegradable or Enteric Nanoparticles following Intravenous and Oral Administration to MiceJournal of Pharmaceutical Sciences, 1995
- Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogsInternational Journal of Pharmaceutics, 1995
- Application of sucrose laurate, a new pharmaceutical excipient, in peroral formulations of cyclosporin AInternational Journal of Pharmaceutics, 1993
- HIV‐1 Protease Inhibitors: Development, Status, and Potential Role in the Treatment of AIDSArchiv der Pharmazie, 1993
- Inclusion complexes of bropirimine with β-cyclodextrin in solution and in solid stateInternational Journal of Pharmaceutics, 1991
- Effects of food on drug absorptionPharmacology & Therapeutics, 1989